Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-002196

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amir Nashat
Director
Period of report
Jan 28, 2019
Accepted (ET)
Jan 30, 2019 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 28, 2019S67,546$13.7824D1,626,157ISee Footnote
Common StockF3,F4Jan 28, 2019S1,316$13.7824D1,624,841ISee Footnote
Common StockF3,F5Jan 28, 2019S463$13.7824D1,624,378ISee Footnote
Common StockF3,F6Jan 28, 2019S675$13.7824D1,623,703ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses